Impact of differential glycemic management goals in pre-anhepatic and anhepatic phase on early grafted liver function after liver transplantation: An open-label, randomized, controlled study
Adopting LIGM (7.8-10.0 mmol/L) during the pre-anhepatic and anhepatic phases helps to reduce the incidence of EAD after LT and promotes the recovery of liver function, but does not increase the incidence of postoperative infections.
Authors
- Zuozhi Li
- Yi Duan (ORCID: https://orcid.org/0000-0002-6229-9461)
- Zhifeng Gao (ORCID: https://orcid.org/0000-0001-6012-7466)
- Huan Zhang (ORCID: https://orcid.org/0000-0001-5640-5697)
- Fulei Gu
- Lei Cui (ORCID: https://orcid.org/0000-0001-7763-5205)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- Journal of Clinical Anesthesia
- Published
- 2025-03-15
- DOI
- https://doi.org/10.1016/j.jclinane.2025.111807
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00